These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 30694582)
1. The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England. Harrison GI; Murray K; Gore R; Lee P; Sreedharan A; Richardson P; Hughes AJ; Wiselka M; Gelson W; Unitt E; Ratcliff K; Orton A; Trinder K; Simpson C; Ryder SD; Oelbaum S; Foster GR; Christian A; Smith S; Thomson BJ; Reynolds R; Harris M; Hickman M; Irving WL Addiction; 2019 Jun; 114(6):1113-1122. PubMed ID: 30694582 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of the HepCATT intervention in specialist drug clinics to improve case-finding and engagement with HCV treatment for people who inject drugs in England. Ward Z; Reynolds R; Campbell L; Martin NK; Harrison G; Irving W; Hickman M; Vickerman P Addiction; 2020 Aug; 115(8):1509-1521. PubMed ID: 31984606 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol). Hickman M; Dillon JF; Elliott L; De Angelis D; Vickerman P; Foster G; Donnan P; Eriksen A; Flowers P; Goldberg D; Hollingworth W; Ijaz S; Liddell D; Mandal S; Martin N; Beer LJZ; Drysdale K; Fraser H; Glass R; Graham L; Gunson RN; Hamilton E; Harris H; Harris M; Harris R; Heinsbroek E; Hope V; Horwood J; Inglis SK; Innes H; Lane A; Meadows J; McAuley A; Metcalfe C; Migchelsen S; Murray A; Myring G; Palmateer NE; Presanis A; Radley A; Ramsay M; Samartsidis P; Simmons R; Sinka K; Vojt G; Ward Z; Whiteley D; Yeung A; Hutchinson SJ BMJ Open; 2019 Sep; 9(9):e029538. PubMed ID: 31551376 [TBL] [Abstract][Full Text] [Related]
4. Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world data. Palmateer NE; McAuley A; Dillon JF; McDonald S; Yeung A; Smith S; Barclay S; Hayes P; Shepherd SJ; Gunson RN; Goldberg DJ; Hickman M; Hutchinson SJ Addiction; 2021 Oct; 116(10):2893-2907. PubMed ID: 33651446 [TBL] [Abstract][Full Text] [Related]
5. Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review. Socías ME; Karamouzian M; Parent S; Barletta J; Bird K; Ti L Int J Drug Policy; 2019 Oct; 72():146-159. PubMed ID: 31147142 [TBL] [Abstract][Full Text] [Related]
6. Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugs. Hassan MRA; Chan HK; Nordin M; Yahya R; Sulaiman WRW; Merican SAA; Lah D; Sem X; Shilton S Harm Reduct J; 2023 Apr; 20(1):48. PubMed ID: 37046294 [TBL] [Abstract][Full Text] [Related]
7. Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era. Valerio H; McAuley A; Innes H; Palmateer N; Goldberg DJ; Munro A; Taylor A; Hutchinson SJ Int J Drug Policy; 2018 Feb; 52():115-122. PubMed ID: 29414462 [TBL] [Abstract][Full Text] [Related]
8. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV). Fadnes LT; Aas CF; Vold JH; Ohldieck C; Leiva RA; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA; BMC Infect Dis; 2019 Nov; 19(1):943. PubMed ID: 31703669 [TBL] [Abstract][Full Text] [Related]
9. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy. Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585 [TBL] [Abstract][Full Text] [Related]
10. Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care. Martin SA; Bosse J; Wilson A; Losikoff P; Chiodo L Addict Sci Clin Pract; 2018 Apr; 13(1):10. PubMed ID: 29690936 [TBL] [Abstract][Full Text] [Related]
11. Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington. Corcorran MA; Tsui JI; Scott JD; Dombrowski JC; Glick SN Drug Alcohol Depend; 2021 Mar; 220():108525. PubMed ID: 33461152 [TBL] [Abstract][Full Text] [Related]
12. Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study. Grebely J; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Phung N; Weltman MD; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Addiction; 2016 Feb; 111(2):311-9. PubMed ID: 26451534 [TBL] [Abstract][Full Text] [Related]
13. Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study. Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore GJ; Grebely J Clin Infect Dis; 2021 Jul; 73(1):e69-e78. PubMed ID: 32421194 [TBL] [Abstract][Full Text] [Related]
14. Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). Fadnes LT; Aas CF; Vold JH; Leiva RA; Ohldieck C; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA; PLoS Med; 2021 Jun; 18(6):e1003653. PubMed ID: 34061883 [TBL] [Abstract][Full Text] [Related]
15. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs. Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494 [TBL] [Abstract][Full Text] [Related]
16. Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol. Klaman SL; Godino JG; Northrup A; Lewis SV; Tam A; Carrillo C; Lewis R; Matthews E; Mendez B; Reyes L; Rojas S; Ramers C BMC Infect Dis; 2024 Jan; 24(1):105. PubMed ID: 38238686 [TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care. Roberts K; Macleod J; Metcalfe C; Hollingworth W; Williams J; Muir P; Vickerman P; Clement C; Gordon F; Irving W; Waldron CA; North P; Moore P; Simmons R; Miners A; Horwood J; Hickman M BMJ; 2020 Feb; 368():m322. PubMed ID: 32102782 [TBL] [Abstract][Full Text] [Related]
18. Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting? Gountas I; Sypsa V; Anagnostou O; Martin N; Vickerman P; Kafetzopoulos E; Hatzakis A Addiction; 2017 Jul; 112(7):1290-1299. PubMed ID: 28107585 [TBL] [Abstract][Full Text] [Related]
19. Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy. Wong GL; Chan HL; Loo CK; Hui YT; Fung JY; Cheung D; Chung C; Chim AM; Wong VW; J Gastroenterol Hepatol; 2019 Sep; 34(9):1641-1647. PubMed ID: 30707777 [TBL] [Abstract][Full Text] [Related]
20. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study. Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Sharafi H; Shafiei M; Zarei J; Mousavian G; Tavakoli F; Ghalekhani N; Shokoohi M; Khezri M; Mehmandoost S; Shojaei MR; Karamouzian M; Briceno A; Morris MD; Alavian SM; Haghdoost AA; Sharifi H; Page KA Int J Drug Policy; 2022 Apr; 102():103580. PubMed ID: 35074607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]